Wall Street Analysts Believe ANI (ANIP) Could Rally 32.4%: Here's is How to TradeZacks Investment Research • 03/07/25
ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled SyringeGlobeNewsWire • 03/03/25
ANI Pharmaceuticals Expects Strong Start To 2025, On Back Of Cortrophin Gel And Generics, Lifts Annual ForecastBenzinga • 02/28/25
ANI (ANIP) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/28/25
ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 GuidanceGlobeNewsWire • 02/28/25
ANI Pharmaceuticals to Present at Raymond James' Institutional Investors and Leerink Partners Global Healthcare Conferences in MarchGlobeNewsWire • 02/19/25
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ETGlobeNewsWire • 02/18/25
ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 OutlookGlobeNewsWire • 01/13/25
ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT ExclusivityGlobeNewsWire • 01/02/25
ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 12/30/24
ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare ConferenceGlobeNewsWire • 11/26/24
Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect?Zacks Investment Research • 11/26/24
ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Surpass EstimatesZacks Investment Research • 11/08/24
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 GuidanceGlobeNewsWire • 11/08/24
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in NovemberGlobeNewsWire • 11/04/24
Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to DeclineZacks Investment Research • 11/01/24